Objective:
Expand the approved uses of Clomid and related medications to include treatment for low testosterone in men as a safer alternative to synthetic testosterone.
Rationale:
- Clomid is already widely used off-label for male infertility and low testosterone, with studies supporting its efficacy.
- Official FDA approval would encourage broader adoption, establish guidelines for safe use, and reduce barriers to insurance coverage.
Action Plan:
- Advocate for clinical trials specifically addressing the use of Clomid and similar medications for male hypogonadism.
- Partner with medical associations to raise awareness about the benefits of off-label use and push for formal approval.